ABBV has been in the news 346% more than usual
Sep 26, 2025, 12:31 PM
4.33%
What does ABBV do
AbbVie is a North Chicago-based biopharmaceutical company that develops and sells medicines across various therapeutic areas, employing 50,000 staff since its IPO in January 2013. Key products include Humira, Botox, and NX-13 for ulcerative colitis.
ABBV has been in the news recently: A U.S. federal judge dismissed challenges from two pharmaceutical companies regarding Maine's law on contract pharmacies under the 340B program. Allergan Aesthetics, a subsidiary of AbbVie, will showcase its AA Signature™ multimodal treatment approach at AMWC Dubai after its successful launch in over 25 countries this year.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.